| 引用本文: | 马伟,方伟杰.中国国家免疫规划现状分析及探讨[J].中国现代应用药学,2025,42(14):116-122. |
| Wei Ma,Weijie Fang.Analysis and discussion on the status quo of national immunization program in China[J].Chin J Mod Appl Pharm(中国现代应用药学),2025,42(14):116-122. |
|
| 摘要: |
| 接种疫苗是预防和控制相关传染性疾病最具成本效益的预防措施。中国国家免疫规划实施40多年以来,已经取得了一定的显著成果。但中国国家免疫规划与世界卫生组织(WHO)建议免疫计划和国外一些发达和发展中国家的免疫规划还存在着一定的差距。本文介绍了中国国家免疫规划疫苗的现状,根据目前中国计划免疫疫苗的现状特点,给出中国国家免疫规划疫苗优化策略的建议,并对未来发展方向进行了探讨。 |
| 关键词: 国家免疫规划 免疫规划疫苗 非免疫规划疫苗 预防接种 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Analysis and discussion on the status quo of national immunization program in China |
|
Wei Ma1, Weijie Fang2
|
|
1.Aim Persistence Biopharmaceutical Co. ltd;2.School of Pharmacy, Zhejiang University
|
| Abstract: |
| China"s national immunization program has been implemented for more than 40 years, and some remarkable results have been achieved. However, there is still a certain gap between China"s national immunization plan and the immunization plan recommended by World Health Organization (WHO) and the immunization plans of some developed and developing countries in the world. This paper introduces the current situation of vaccines in China"s National immunization Program, and according to the current characteristics of planned immunization vaccines in China, gives suggestions on vaccine optimization strategies in China"s national immunization program, and prospects the future development direction. |
| Key words: National Immunization Program Immunization program vaccine Non-immunization program vaccine Prophylactic vaccination |
